ETF Components for CHNA - Loncar China BioPharma ETF

Below is a list of stocks held by this ETF. We only list holdings in the same market. If this is a global ETF, there may be additional components other than those listed here.


Symbol Grade Price % Change Allocation
GTH D 0.00 1.43
CASI F 0.00 0.90

Recent News for Loncar China BioPharma ETF & its Holdings

The investment seeks to track the performance, before fees and expenses, of the Loncar China BioPharma Index (the index). Under normal circumstances, at least 80% of the fund's total assets (exclusive of any collateral held from securities lending) will be invested in the component securities of the index or in depositary receipts representing such component securities. The index seeks to track the performance of a modified equal-weighted portfolio of companies directly involved in the growth of China's pharmaceutical and biotech related industries. The fund is non-diversified.
Exchange Traded Fund ETF Institutional Investors Short Selling Lonca Loncar Cancer Immunotherapy Index
Back to the Main CHNA Page...